Is oral semaglutide a game changer or nice-to-have for type 2 diabetes? (with Neil Skolnik)
Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College in Philadelphia, Pennysylvania, USA, gives his view and outlines key considerations for the use of this new medication as part of a shared decision-making process with people who have type 2 diabetes.
For more of the latest news and insights on diabetes medications, visit: https://bit.ly/MMd_medications
Create your
podcast in
minutes
It is Free